We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com. Cryptococcal meningitis caused an estimated 15% of ...
Worldwide, cryptococcal meningitis kills up to 180,000 persons annually and is the most common cause of nonviral meningitis in the United States. Besides patients with immunosuppression due to human ...
This double-blind trial enrolled adults with HIV-associated cryptococcal meningitis in Vietnam, Thailand, Indonesia, Laos, Uganda, and Malawi. All patients received combination antifungal therapy of ...
Amphotericin B iv. 0.7–1 mg/kg q.d., plus flucytosine o.s. 25 mg/kg q.i.d. Fluconazole o.s./iv. 800–1200 mg q.d. Fluconazole o.s./iv. 400 mg q.d. Fluconazole o.s ...
A common first-line treatment approach for cryptococcal meningitis in low-income countries is being compromised by the emergence of drug resistance, new University of Liverpool research warns.
Introduction Cryptococcal meningitis (CM) is an infection of the central nervous system that accounts for approximately 19% ...
A new short-course treatment is effective against HIV-associated cryptococcal meningitis with fewer serious side effects, and has the potential to reduce the length and cost of hospital admissions, a ...
Helen Bygrave, MD, chronic diseases advisor for the Médecins Sans Frontières (MSF; Doctors Without Borders) Access Campaign, explains how the campaign is aiming to eliminate the threat of cryptococcal ...
SSUCv3H4sIAAAAAAAEAIVSy27DIBC8V+o/WJxj1WDHxf2CXvoFUQ8YNjaKYyIMqarI/971g5SmUnJjZ2eH2cfl+SlJSC0GLclbcpkijHXX ...
Dar es Salaam / Lilongwe / Geneva — 15 April 2025 — A new, easier-to-administer and patient-friendly sustained-release formulation of flucytosine, a medicine used to treat cryptococcal meningitis, has ...
Crytococcal meningitis is a deadly invasive fungal infection which affects hundreds of thousands of HIV patients in the late stage of their disease every year. Crytococcal meningitis is a deadly ...
ABOUT 500 cases of human infection due to Cryptococcus neoformans have been described since Busse and Buschke separately presented descriptions of clinical findings in the same patient. In addition ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results